PAVmed Inc.
PAVMNasdaqCIK 1624326HealthcareFiscal year ends Dec 31
Reports and events: 282 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2221:28 ET | 8-K | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001493152-26-048138 |
| 2026-09-1023:15 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-042021 |
| 2026-08-1414:44 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-038072 |
| 2026-08-1321:03 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001437749-26-027733 |
| 2026-06-2421:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-029944 |
| 2026-05-1512:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-023352 |
| 2026-05-1421:17 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001437749-26-017121 |
| 2026-04-3013:28 ET | DEF 14A | Proxy statementPeriod 2026-04-30 | 0001493152-26-020705 |
| 2026-04-0900:56 ET | SCHEDULE 13D | Ownership report, active investor | 0001094891-26-000179 |
| 2026-03-3012:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-013477 |
| 2026-03-2721:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-013264 |
| 2026-03-2721:08 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001437749-26-010115 |
| 2026-02-2421:15 ET | DEF 14A | Proxy statementPeriod 2026-02-24 | 0001493152-26-007884 |
| 2026-02-0413:12 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-005023 |
| 2026-01-2321:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-003409 |
| 2025-12-3014:00 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-029510 |
| 2025-12-0521:15 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-25-026368 |
| 2025-11-1313:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-022122 |
| 2025-11-1222:23 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001493152-25-022017 |
| 2025-10-3120:05 ET | DEF 14A | Proxy statementPeriod 2025-10-31 | 0001493152-25-020379 |
| 2025-09-1113:28 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-013048 |
| 2025-08-1412:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-023729 |
| 2025-08-1400:04 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001493152-25-011923 |
| 2025-07-3012:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-011491 |
| 2025-06-2412:15 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001641172-25-016227 |
| 2025-06-1821:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001641172-25-015612 |
| 2025-05-1512:25 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-010536 |
| 2025-05-1501:32 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001641172-25-010433 |
| 2025-04-3020:15 ET | DEF 14A | Proxy statementPeriod 2025-04-30 | 0001641172-25-007773 |
| 2025-04-2520:52 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001641172-25-006250 |
| 2025-04-1721:12 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001641172-25-005279 |
| 2025-04-1113:27 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-003741 |
| 2025-03-2512:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-000517 |
| 2025-03-2421:22 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001641172-25-000364 |
| 2025-03-1020:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-009698 |
| 2025-02-2122:00 ET | 8-K | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-25-007902 |
| 2025-02-1813:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-007094 |
| 2025-01-2422:15 ET | 8-K | 3.01 Delisting notice; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001493152-25-003631 |
| 2025-01-2121:30 ET | 8-K | 3.01 Delisting notice; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-003053 |
| 2025-01-1521:45 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-25-002398 |
| 2024-12-0621:15 ET | DEF 14A | Proxy statementPeriod 2024-12-06 | 0001493152-24-049070 |
| 2024-11-2921:21 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001493152-24-048173 |
| 2024-11-2121:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001493152-24-047156 |
| 2024-11-1413:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-045362 |
| 2024-11-1402:29 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001493152-24-045258 |
| 2024-09-1620:05 ET | 8-K | 2.01 Completion of an acquisition or disposition; 3.01 Delisting notice; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-036380 |
| 2024-08-1312:18 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-031471 |
| 2024-08-1220:08 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001493152-24-031268 |
| 2024-06-2021:00 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-24-024540 |
| 2024-05-1414:38 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-019117 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. Listed shows no prices and gives no investment advice.